21055 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
mGluR receptor antagonists for use in prevention andor treatment of bone marrow lesions (BML) andor osteoporosis, cartilage loss, osteosclerosis and osteitis in a mammal
#2HIRUDIN FORMULA COMPOSITION WITH ANTICOAGULANT AND HYPOLIPIDEMIC EFFECTS AND PREPARATION METHOD THEREOF
#3METHODS OF TREATING OR PREVENTING STENT THROMBOSIS
#4THROMBIN AND FIBRINOGEN AS TARGETS FOR ATOPIC DERMATITIS DIAGNOSIS AND TREATMENT
#5METHODS OF TREATING OR PREVENTING STENT THROMBOSIS
#6READY-TO-USE BIVALIRUDIN COMPOSITIONS
#7Ready-to-use bivalirudin compositions
#8TARGETED DRUG DELIVERY TO SITES OF INTRAVASCULAR OCCLUSION
#9Ready-to-use bivalirudin compositions
#10LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES
#11COMPOSITIONS AND METHOD OF MODULATING GROWTH FACTOR FUNCTION
#12INJECTABLE HIGH CONCENTRATION PHARMACEUTICAL FORMULATIONS AND METHODS OF MANUFACTURING AND USE THEREOF
#13UNIT DOSAGE FORM FOR TRANSMUCOSAL DRUG DELIVERY OF AN ACTIVE PHARMACEUTICAL INGREDIENT
#14METHOD FOR INHIBITING PLATELET DERIVED GROWTH FACTOR SIGNALING WITH C3aR OR C5aR ANTIBODIES
#15Lipoprotein targeting protease inhibitors and uses
#16NOVEL HUMANIZED ANTIBODIES AGAINST FACTOR XI HAVING ANTI-THROMBOTIC AND ANTI-INFLAMMATORY EFFECT AND USES THEREOF
#17PEPTIDE DIRECTED PROTEIN KNOCKDOWN
#18METHODS OF TREATING OR PREVENTING STENT THROMBOSIS
#19Ready-to-use bivalirudin compositions
#20LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES
#21Peptide directed protein knockdown
#22HAEMADIPSA SYLVESTRIS ANTITHROMBOTIC PEPTIDE SYLVESTIN AND USE THEREOF
#23Methods of treating or preventing stent thrombosis
#24Cardiovascular disease treatment and prevention
#25Compositions and methods for cell transplantation
#26LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES
#27STABLE INJECTABLE COMPOSITION OF BIVALIRUDIN AND PROCESS FOR ITS PREPARATION
#28Compositions and methods for cell transplantation
#29PROCESS FOR PRODUCTION OF BIVALIRUDIN
#30COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#31Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces
#32Cardiovascular disease treatment and prevention
#33AQUEOUS BUFFER-FREE BIVALIRUDIN COMPOSITIONS
#34Peptide directed protein knockdown
#35Factor Xa inhibitor used with liver-derived progenitor cells
#36Method of controlling coagulation
#37Cardiovascular disease treatment and prevention
#38COMPOSITIONS AND METHODS FOR CELL TRANSPLANTATION
#39Treatment of diabetic patients with a drug eluting stent and adjunctive therapy
#40PROCESS FOR PRODUCTION OF BIVALIRUDIN
#41PROCESS FOR PRODUCTION OF BIVALIRUDIN
#42PROCESS FOR PRODUCTION OF BIVALIRUDIN
#43PROCESS FOR PRODUCTION OF BIVALIRUDIN
#44PROCESS FOR PRODUCTION OF BIVALIRUDIN
#45PROCESS FOR PRODUCTION OF BIVALIRUDIN
#46METHODS OF TREATMENT OF PATIENTS AT INCREASED RISK OF DEVELOPMENT OF ISCHEMIC EVENTS AND COMPOUNDS HEREOF
#47Method for inhibiting platelet derived growth factor signaling with C3aR or C5aR antibodies
#48Transdermal delivery system for therapeutics
#49ORALLY ABSORBED PHARMACEUTICAL FORMULATION AND METHOD OF ADMINISTRATION
#50METHODS OF MANAGING THE BLOOD COAGULATION AND PHARMACEUTICAL COMPOSITIONS RELATED THERETO
#51Method of treating thrombocytopenia
#52METHODS FOR EFFECTING REGRESSION OF TUMOR MASS AND SIZE IN A METASTASIZED TUMOR
#53Methods of treating or preventing stent thrombosis
#54READY-TO-USE BIVALIRUDIN COMPOSITIONS
#55COMBINATION THERAPY FOR TREATING HEPATITIS VIRAL INFECTION
#56PROCESS FOR PRODUCTION OF BIVALIRUDIN
#57New Pharmaceutical Compositions for Treatment of Thrombosis
#58USE OF COAGULATION PROTEINS TO LYSE CLOTS
#59New Indications for Direct Thrombin Inhibitors
#60PROCESS FOR PRODUCTION OF BIVALIRUDIN
#61METHODS FOR CONTROLLING ANGIOGENESIS AND CELL PROLIFERATION
#62Novel Use of Bivalirudin in the Treatment of Acute Coronary Syndrome
#63Orally Absorbed Pharmaceutical Formulation and Method of Administration
#64CELL-SURFACE DECORATION WITH ACTIVE AGENTS
#65Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway
#66Biomolecule-linked biomimetic scaffolds
#67Indications for Direct Thrombin Inhibitors
#68Biocompatible stent
#69New Indications for Direct Thrombin Inhibitors in the Cardiovascular Field
#70Combination drug therapy for reducing scar tissue formation
#71Use of Increased Molecular-Weight Hirudin as an Anticoagulant in Extracorporeal Kidney Replace Therapy
#72Compositions capable of facilitating penetration across a biological barrier
#73Combined Cosmetic or Therapeutic Preparation
#74Use of nitric oxide adducts
#75Tissue preservation with a salt solution isotonic with interstitial fluids
#76Process for production of Bivalirudin
#77Coagulation proteins, coagulation-anticoagulation protein complexes, derivatives thereof and their uses
#78Use of coagulation proteins to lyse clots
#79NEW PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF THROMBOSIS
#80Method for reducing obstructive hydrocephalus
#81Method of treating hit patients with argatroban
#82Leech extracts for stents
#83Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
#84Eglin c based drugs for treatment of disease
#85Method and device for feeding living cells into a biological body fluid
#86Combination drug therapy for reducing scar tissue formation
#87Compositions capable of facilitating penetration across a biological barrier